Armata Pharmaceuticals (ARMP) Profit After Tax Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.83% |
| Dec 31, 2025 | -79.75% |
| Sep 30, 2025 | -35.83% |
| Jun 30, 2025 | -28.18% |
| Mar 31, 2025 | -5.16% |
| Dec 31, 2024 | -7.79% |
| Sep 30, 2024 | 4.65% |
| Jun 30, 2024 | 32.86% |
| Mar 31, 2024 | -46.25% |
| Dec 31, 2023 | -78.31% |
| Sep 30, 2023 | -62.25% |
| Jun 30, 2023 | -2.29% |
| Mar 31, 2023 | -35.83% |
| Dec 31, 2022 | -34.40% |
| Sep 30, 2022 | -61.71% |
| Jun 30, 2022 | -7.36% |
| Mar 31, 2022 | -22.00% |
| Dec 31, 2021 | 8.64% |
| Sep 30, 2021 | -17.94% |
| Jun 30, 2021 | -9.97% |
| Mar 31, 2021 | -12.04% |
| Dec 31, 2020 | -24.32% |
| Sep 30, 2020 | -25.07% |
| Jun 30, 2020 | -19.50% |
| Mar 31, 2020 | 18.92% |
| Dec 31, 2019 | 51.10% |
| Sep 30, 2019 | -18.41% |
| Jun 30, 2019 | -18.15% |
| Mar 31, 2019 | 19.85% |
| Dec 31, 2018 | -34.51% |
| Sep 30, 2018 | 43.65% |
| Jun 30, 2018 | 26.38% |
| Mar 31, 2018 | -13.76% |